Genomic rearrangement screening of the BRCA1 from seventy Iranian high-risk breast cancer families

Abstract

Background:The second leading cause of cancer deaths in women is breast cancer. Germline mutations in susceptibility breast cancer gene BRCA1 increase the lifetime risk of breast cancer. Eighty-one large genomic rearrangements (LGRs) have been reported up to date in BRCA1 gene, and evaluation of these rearrangements helps with precise risk assessment in high-risk individuals. In this study, we have investigated LGRs in BRCA1 among Iranian high-risk breast cancer families.Materials and Methods:Seventy patients with breast cancer who were identified negative for point mutations or small deletions/insertions of BRCA1 gene were selected. Deletions and duplications of BRCA1 gene were evaluated using multiplex ligation-dependent probe amplification (MLPA).Results:Two deletions, deletion of exons 1A/1B-2 and exon 24, were detected in two patients with breast cancer. The former alteration was found in a woman with a strong family history of breast cancer while the latter one was detected in a woman with early onset of breast cancer.Conclusion:Although our data confirm that LGRs in BRCA1 comprise a relatively small proportion of mutations in hereditary breast cancer in the Iranian population, MLPA analysis might be considered for screening of LGRs in high-risk individuals. It is worth to note that our results are consistent with previous studies in various Asian and European countries.

Germline <em>BRCA1</em> and <em>BRCA2</em> deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India

“…Previous reports denoted Yes are cited in the databases mentioned in the “Materials and methods” section. a Reported previously by Suryavanshi et al 23 b Reported by Hogervorst et al 24 c Reported by Machackova et al 25 d Reported by Armaou et al, 26 Engert et al 27 and Sedghi et al 28 e Reported by Zorrieh Zahra et al 29 …”

Age at Diagnosis of Breast Cancer in Iran: A Systematic Review and Meta-Analysis

“…However, our results could have some biases since we only considered studies without any limitation in patients’ selection part in order to generalize the study population. Therefore, the studies evaluating the specific age groups (both young and elderly groups of women) ( 27 , 28 ), postmenopausal women ( 29 ), high risk patients ( 30 ) or studies containing patients with specific immunohistochemistry profile ( 31 ) have been excluded. Moreover, another limitation was geographic distribution of included studies, in which the included patients to the meta-analysis were from 17 out of 31 provinces of Iran.…”